Launched in 1994, VISIPAQUE is a contrast media available in Canada. VISIPAQUE is approved for a range of diagnostic procedures requiring intravascular contrast, such as coronary angiography, CT, IVP, and venography.

NOT FOR INTRATHECAL USE.

All nonionic, iodinated contrast media currently available inhibit blood coagulation, in vitro, less than ionic contrast media. Clotting has been reported when blood remains in contact with syringes containing nonionic contrast media. Serious, rarely fatal, thromboembolic events causing myocardial infarction and stroke have been reported during angiographic procedures with both ionic and nonionic contrast media. Therefore, meticulous intravascular administration technique is necessary to minimize thromboembolic events.